Marcus Irsfeld
Gründer bei Artract Medical, Inc.
Profil
Marcus Irsfeld is the founder of Artract Medical, Inc. Prior to founding Artract Medical, he worked as the Chief Financial Officer at ProCorde GmbH from 2001 to 2005.
He also worked as a Controller at Trigen Holdings AG in 2009.
Mr. Irsfeld received his undergraduate degree from the University of Münster.
Aktive Positionen von Marcus Irsfeld
| Unternehmen | Position | Beginn |
|---|---|---|
Artract Medical, Inc.
 Artract Medical, Inc. Medical SpecialtiesHealth Technology Artract Medical, Inc. is a medical device company based in New York, NY. The company has developed a passive hemodynamic assist device called the Artract System, which is implanted percutaneously to treat heart failure with preserved ejection fraction (HFPEF). HFPEF is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. The Artract System reduces shortness of breath, improves exercise tolerance, and reduces the need for daily medication and frequent hospital stays. The company was founded by Marcus Irsfeld and Wolfgang Gœtz. | Gründer | - |
Ehemalige bekannte Positionen von Marcus Irsfeld
| Unternehmen | Position | Ende |
|---|---|---|
Trigen Holdings AG
 Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Trigen Holdings AG develops drugs focusing on thrombosis and vascular dysfunction. Its product pipeline includes clinical stage candidates, TGN 255, TGN 167 and PR-15. The company has offices in London. Trigen Holdings was founded in 2005 and is headquartered in Martinsried, Germany. | Comptroller/Controller/Auditor | 15.12.2009 |
ProCorde GmbH
 ProCorde GmbH Miscellaneous Commercial ServicesCommercial Services Founded in 2000,Precorde GmbH develops biotechnology for the integrated development of biomedical drugs in cardiovascular diseases. | Finanzdirektor/CFO | 11.04.2005 |
Ausbildung von Marcus Irsfeld
| University of Münster | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
ProCorde GmbH
ProCorde GmbH Miscellaneous Commercial ServicesCommercial Services Founded in 2000,Precorde GmbH develops biotechnology for the integrated development of biomedical drugs in cardiovascular diseases. | Commercial Services |
Trigen Holdings AG
Trigen Holdings AG Miscellaneous Commercial ServicesCommercial Services Trigen Holdings AG develops drugs focusing on thrombosis and vascular dysfunction. Its product pipeline includes clinical stage candidates, TGN 255, TGN 167 and PR-15. The company has offices in London. Trigen Holdings was founded in 2005 and is headquartered in Martinsried, Germany. | Commercial Services |
Artract Medical, Inc.
Artract Medical, Inc. Medical SpecialtiesHealth Technology Artract Medical, Inc. is a medical device company based in New York, NY. The company has developed a passive hemodynamic assist device called the Artract System, which is implanted percutaneously to treat heart failure with preserved ejection fraction (HFPEF). HFPEF is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. The Artract System reduces shortness of breath, improves exercise tolerance, and reduces the need for daily medication and frequent hospital stays. The company was founded by Marcus Irsfeld and Wolfgang Gœtz. | Health Technology |
